Showing 1 posts of 1 posts found.
Valeant is striking out in the acquisitions market yet again, having agreed an $800 million deal to buy Egypt’s largest …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO